Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M KOSAK

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Acta Anatomica|January 1, 1983
Anatomic topographical relationship of the intraspinal accessory root to the upper cervical roots and to the vessels of the cranial cervical regionR Hagenah, M Kosak, N Freckmann
Acta Chirurgica Iugoslavica|January 1, 1981
[Echinococcosis of the heart]M Kosak, I Obrez, J Jezernik, et al.
Acta Chirurgica Iugoslavica|January 1, 1981
[Fibromyxoma of the left ventricle as a cause of heart aneurysm and recurrent thromboembolism]M Kosak, B Pust, I Obrez, et al.
Drug Delivery and Translational Research|January 13, 2015
Drug-free macromolecular therapeutics induce apoptosis of patient chronic lymphocytic leukemia cellsTe-Wei Chu, Ken M Kosak, Paul J Shami, et al.
European Journal of Organic Chemistry|December 23, 2015
Ether Cleavage Re-Investigated: Elucidating the Mechanism of BBr<sub>3</sub>-Facilitated Demethylation of Aryl Methyl EthersTalon M Kosak, Heidi A Conrad, Andrew L Korich, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 10, 2014
An extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemiaImit Kaur, Jonathan E Constance, Ken M Kosak, et al.
The Journal of Pharmacy and Pharmacology|August 10, 2013
Cellular distribution studies of the nitric oxide-generating antineoplastic prodrug O(2) -(2,4-dinitrophenyl)1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate formulated in Pluronic P123 micellesImit Kaur, Moises Terrazas, Ken M Kosak, et al.
Pharmaceutical Research|October 22, 2014
Effect of a Pluronic(®) P123 formulation on the nitric oxide-generating drug JS-KImit Kaur, Ken M Kosak, Moises Terrazas, et al.
Leukemia Research|February 6, 2009
JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C)Paul J Shami, Anna E Maciag, Jordan K Eddington, et al.
Physiological Research|September 27, 2017
Can the gold standard be beaten? How reliable are various modifications of the Synacthen test compared to the insulin tolerance testM Kosak, M Duskova, L Starka, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Acta Anatomica|January 1, 1983
Anatomic topographical relationship of the intraspinal accessory root to the upper cervical roots and to the vessels of the cranial cervical regionR Hagenah, M Kosak, N Freckmann
Acta Chirurgica Iugoslavica|January 1, 1981
[Echinococcosis of the heart]M Kosak, I Obrez, J Jezernik, et al.
Acta Chirurgica Iugoslavica|January 1, 1981
[Fibromyxoma of the left ventricle as a cause of heart aneurysm and recurrent thromboembolism]M Kosak, B Pust, I Obrez, et al.
Drug Delivery and Translational Research|January 13, 2015
Drug-free macromolecular therapeutics induce apoptosis of patient chronic lymphocytic leukemia cellsTe-Wei Chu, Ken M Kosak, Paul J Shami, et al.
European Journal of Organic Chemistry|December 23, 2015
Ether Cleavage Re-Investigated: Elucidating the Mechanism of BBr<sub>3</sub>-Facilitated Demethylation of Aryl Methyl EthersTalon M Kosak, Heidi A Conrad, Andrew L Korich, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 10, 2014
An extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemiaImit Kaur, Jonathan E Constance, Ken M Kosak, et al.
The Journal of Pharmacy and Pharmacology|August 10, 2013
Cellular distribution studies of the nitric oxide-generating antineoplastic prodrug O(2) -(2,4-dinitrophenyl)1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate formulated in Pluronic P123 micellesImit Kaur, Moises Terrazas, Ken M Kosak, et al.
Pharmaceutical Research|October 22, 2014
Effect of a Pluronic(®) P123 formulation on the nitric oxide-generating drug JS-KImit Kaur, Ken M Kosak, Moises Terrazas, et al.
Leukemia Research|February 6, 2009
JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C)Paul J Shami, Anna E Maciag, Jordan K Eddington, et al.
Physiological Research|September 27, 2017
Can the gold standard be beaten? How reliable are various modifications of the Synacthen test compared to the insulin tolerance testM Kosak, M Duskova, L Starka, et al.
Pageof 2